Every Picture Tells A Story

With their support, and generous donations from individuals, foundations and corporations, SU2C’s 19 research Dream Teams are making real progress toward our goal of turning cancer into a disease that’s manageable and survivable. The funds we have raised help drive the innovative research that has led to 160 clinical trials of new treatments, involving more than 9,000 patients. It’s been said in years past, but it’s never been truer than it is right now, that we are at a critical point in this race. We’ve never been closer to the finish line and I’ve never been more optimistic we will cross it. But, we need your help.

When we started Stand Up To Cancer back in 2008, we knew the two things it would take to change the face of cancer: brains and money. For the former, we enlisted the brightest minds at leading research institutions around the world to be bold, innovate, and most of all, collaborate instead of compete. For the money, we aimed to harness the star power of Hollywood not only to raise awareness, but to attract donations—big and small.

Fast-forward eight years, and I’m excited to report that our SU2C funding model is producing results beyond what we ever imagined. Right now, two FDA-approved therapies resulting from SU2C clinical trials are helping patients—and there are more promising treatments on the way.

For me, cancer is personal; given the statistics, it’s likely to be personal for all of us. I can’t change my past, but I can do everything in my power to try to change the future by supporting the scientists whose research and discoveries give others the hope they need to fuel the fight.

I hope you’ll read the stories and look at the photos that so many others have posted… and use #Reasons2StandUp on Facebook, Twitter, and Instagram to share yours. Be sure to watch the SU2C telecast tonight, Friday, September 9, at 8 PM/7 CT to see your favorite film and TV stars, music artists, and cancer survivors share their reasons.

We all have a reason to stand up. What’s yours?